lenalidomide has been researched along with Cryoglobulinemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyapati, A; Khan, S; Mar, A; Sheridan, A | 1 |
Ando, K; Hata, T; Imaizumi, Y; Imanishi, D; Makiyama, J; Miyazaki, Y; Sawayama, Y; Taguchi, J; Taniguchi, H; Tsushima, H | 1 |
Curran, JJ; Lin, RJ; Niewold, TB; Song, J; Sweiss, NJ; Zimmerman, TM | 1 |
Calabrese, C; Calabrese, LH; Faiman, B; Martin, D; Reu, F | 1 |
Boileau, J; Goetz, J; Gorse, A; Martin, T; Stoll-Keller, F | 1 |
5 other study(ies) available for lenalidomide and Cryoglobulinemia
Article | Year |
---|---|
Reactive angioendotheliomatosis associated with cyroglobulinemia in a marathon runner.
Topics: Aged; Angiogenesis Inhibitors; Cryoglobulinemia; Hemangioendothelioma; Humans; Lenalidomide; Male; Running; Skin Neoplasms; Thalidomide | 2013 |
[Successful treatment with a combination of lenalidomide and dexamethasone for cryoglobulinemia associated with multiple myeloma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Dexamethasone; Female; Humans; Lenalidomide; Multiple Myeloma; Plasmapheresis; Thalidomide | 2014 |
Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.
Topics: Adult; Antineoplastic Agents; Cryoglobulinemia; HLA-B27 Antigen; Humans; Lenalidomide; Lumbar Vertebrae; Male; Multiple Myeloma; Sacroiliac Joint; Spondylarthropathies; Thalidomide | 2010 |
Type 1 cryoglobulinemia: response to thalidomide and lenalidomide.
Topics: Cryoglobulinemia; Humans; Immunosuppressive Agents; Lenalidomide; Male; Middle Aged; Thalidomide; Treatment Outcome | 2011 |
Parvovirus B19-induced type II mixed cryoglobulinemia.
Topics: Acute Disease; Antibodies, Viral; Antineoplastic Agents; Cryoglobulinemia; Diagnosis, Differential; DNA, Viral; Glomerulonephritis, Membranoproliferative; Humans; Lenalidomide; Male; Middle Aged; Parvoviridae Infections; Parvovirus B19, Human; Thalidomide; Viral Load; Virulence | 2011 |